Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
anlotinib (1 trial)
Epimedium (1 trial)
huachansu pian (1 trial)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Lung Neoplasms (Phase 4)
Small Cell Lung Carcinoma (Phase 4)
Trials (2 total)
Trial APIs (3 total)